Navigation Links
AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
Date:9/21/2009

LONDON and SAN CARLOS, Calif., Sept. 21 /PRNewswire-FirstCall/ -- AstraZeneca and Nektar Therapeutics announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118, a late stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early stage programme that is intended to deliver products for the treatment of pain without constipation side effects. Both programmes were developed by Nektar, utilizing their proprietary small molecule advanced polymer conjugate technology platform.

Under the terms of the agreement, AstraZeneca will assume the responsibility for the continued development of both the NKTR-118 and NKTR-119 programmes, including the initiation of late-stage clinical studies for NKTR-118. AstraZeneca expects completion of the design of the phase III programme in the near term, and anticipates filing the drug with regulators in 2013. AstraZeneca will also be responsible for global manufacturing and marketing for both programmes. Under the agreement, Nektar will receive an upfront payment of $125 million for both NKTR-118 and NKTR-119.

NKTR-118 has completed a Phase 2 clinical trial and is being developed to treat constipation caused by the use of opioid pain products. Under the agreement, for NKTR-118, Nektar is eligible to receive up to $235 million in aggregate payments upon the achievement of certain regulatory milestones, as well as additional tiered sales milestone payments of up to $375 million if the product achieves considerable levels of commercial success. Nektar will also be eligible to receive significant double-digit royalty payments on net sales of NKTR-118 worldwide.

NKTR-119 is an early stage drug development programme that is intended to combine oral NKTR-118 with selected opioids, with the goal of treating
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
2. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
3. AstraZeneca and Banner Alzheimers Institute Collaborate to Evaluate New Tool Targeting Alzheimers Disease
4. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
5. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
6. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
8. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
9. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
10. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
11. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...a. and WALTHAM, Mass., Nov. 19 Arl...ces find that the leading driver of antibiotic sel...spectrum activity against gram-positive and gram-n... that can cause nosocomial pneumonia, surveyed Eur...or agents that provide appropriate coverage agains...
(Date:11/19/2009)... InSound is honored by latest award for revolution..., CA (PRWEB) November 16, 2009 -- Popular Science ...o; hearing aid from InSound Medical a winner of it...alth category.    Chosen from ... deep in the hearing canal for up to four months w...
(Date:11/18/2009)...ine a polka-dotted postage stamp that can sniff ou...ing colors. , As reported in the Sept. 13 issue ... and his team at the University of Illinois have d...ion of toxic industrial chemicals (TICs) that is s...ing odors. This sensor array could be useful in d...
(Date:11/18/2009)..., West Sussex, U.K. and CLEVELAND, Nov. 18 /PRNews...iences business and premier provider of diagnostic...ogy labs, has expanded its East Grinstead, U.K., m... to meet increasing global demand for its Sensitit...ification testing. The expanded facility has been ...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
...f., Dec. 3 Portola,Pharmaceuticals, a biopharmace...ovide significant advances in cardiovascular disea...ed that data related to the Company,s series of no...(Syk) and its novel universal,Factor Xa inhibitor ...f the,American Society of Hematology (ASH) at the ...
...Medarex, Inc.,(Nasdaq: MEDX ) announced today th...arkets Healthcare Conference at 3:30 p.m. Eastern ...l be webcast live and will be available in the,Inv... www.medarex.com . An,archived edition of the pres... About Medarex , Medarex is a biopharma...
... Despite roller-coaster changes in the U.S. and w...mployment could be counted on once again: tens of ... yearly growth up over 345,000.The MedZilla.com Em...008 and announces the findings. , ...he U.S. economy experienced some subtle and &ndash...
Other Biology Technology:Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting 2Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting 3The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health 3
(Date:11/19/2009)..., multi-institutional effort co-led by three Cold ...ted today in publication of a landmark series of p...edented detail the DNA sequence of maize ( Zea may...orth American consumers, is one of the world,s mos...ral crop grown in the United States, representing ...
(Date:11/19/2009)...wswire-FirstCall/ -- BIO-key International, Inc. (...blic safety and finger-based biometric identificat...der Meeting held today was adjourned without any a.... ,, (Logo: http://www.newscom.com/cgi-bin/prn...9.3% of the 35 million votes cast voted in favor o...
(Date:11/19/2009)...tainable farming, initially adopted to preserve so... role in maintaining a healthy climate, according ...idge and Los Alamos national laboratories. , ORN...ntial of the earth,s soils to sequester carbon, wi...could greatly reduce U.S. carbon emissions by as m...
Breaking Biology News(10 mins):Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3JGI Completes Successful Upgrade of ADP Enterprise V5 at Washington Hospital Healthcare System 59522 1JGI Completes Successful Upgrade of ADP Enterprise V5 at Washington Hospital Healthcare System 59522 2ZyGEM Releases Data Confirming its prepGEM 28R 29 Insect Kit is a Simple Rapid Method for Extracting Insect DNA for Species Identification 14482 1ZyGEM Releases Data Confirming its prepGEM 28R 29 Insect Kit is a Simple Rapid Method for Extracting Insect DNA for Species Identification 14482 2ZyGEM Releases Data Confirming its prepGEM 28R 29 Insect Kit is a Simple Rapid Method for Extracting Insect DNA for Species Identification 14482 3ZyGEM Releases Data Confirming its prepGEM 28R 29 Insect Kit is a Simple Rapid Method for Extracting Insect DNA for Species Identification 14482 4Department of Energy Grants BlueFire Approval for Site Change 14479 1Department of Energy Grants BlueFire Approval for Site Change 14479 2Department of Energy Grants BlueFire Approval for Site Change 14479 3Department of Energy Grants BlueFire Approval for Site Change 14479 4
...y presented at the Experimental Biology Annual Mee... canola, Dermytol, produces a pronounced reduction...oprietary compound developed by KGK Synergize Inc....signed to protect skin cells from damage that may ... KGK Synergize Incs Scientific Director, said, Ski...
...mental enrichment and increased social stress can ...rding to new monkey research at Wake Forest Univer...as shown that social rank whether animals are dom...an affect the amount of cocaine that monkeys will ...nomolgus monkeys will invariably stratify by socia...
...esearchers have found that rare mutations in three...he general population. , The scientists had previo...ng genes cause several rare diseases that are char... samples obtained from 3,125 people who are partic...hers identified new functional mutations in these ...
Other Biology News:New study shows Dermytol produces pronounced decrease in malignant melanoma tumor volume 2Environmental enrichment can reduce cocaine use, researchers find 2Rare genetic mutations protect against hypertension 2Rare genetic mutations protect against hypertension 3Rare genetic mutations protect against hypertension 4
Adaptor BamH I-Sma I from Takara Mirus Bio
Adaptor EcoR I Sma I from Takara Mirus Bio
Cassette, EcoR I from Takara Mirus Bio
Newborn Calf Serum from Lifeblood Medical, Inc.
Biology Products: